MercadoLibre Inc. (MELI.NASDAQ) AI OPINIONS & ADVISOR ANALYSIS

The bull case activates when margin expansion and funding relief arrive together. Brazilian easing continues toward 12%, cutting credit-book funding cost while asset yields lag, and Mexican device drag annualises out; EBIT margin re-crosses 10% during 2028 with revenue still compounding above 25%. Advertising scales on an 89-million-buyer base, and cross-border tax tightening blunts Shopee and Temu. Earnings then compound faster than revenue, the multiple stops compressing, and the shares re-rate toward the high three thousands.

The bear case begins the quarter origination slows. Growth deceleration exposes unseasoned 2025-2026 cohorts, over-90-day delinquencies climb, and provisions consume the interest income that justified the build \u2014 with credit cards at 37% of exposure, the tail is long. Simultaneous Argentine contraction and Brazilian post-election fiscal stress hit dollar-translated revenue and funding spreads. Earnings fall while leverage sits at 1.7x equity, and a 48x multiple on shrinking EPS compresses violently toward the low thousands.

The settled belief is that margin compression is voluntary and therefore reversible: 20 of 24 analysts rate MELI Buy with an average target near USD 2,265 [19][20]. The anchoring bias is the 2023-2024 margin peak, treated as a birthright rather than a cyclical high. Tellingly, a Q2 EPS beat still triggered a 4.31% after-hours decline [3] \u2014 the crowd buys the story but no longer pays for the print.

The crowd modestly overestimates near-term earnings power while underestimating the franchise's terminal position. The decisive overlooked evidence is measurement: headline TTM free cash flow of USD 12.46bn implies a 13.75% yield, yet reported adjusted free cash flow was USD 214m in Q2 2026 [1], because restricted cash and customer funds payable inflate the series [2]. Anyone anchoring on that yield is valuing float as owner earnings. Strip it out and the stock is fairly, not cheaply, priced \u2014 an attractive compounder without a margin of safety.

The quarterly EBIT margin print is the price-setting variable, not revenue. The first sequential margin expansion alongside decelerating credit-book growth \u2014 plausibly in the Q4 2027 or Q1 2028 releases \u2014 would confirm reinvestment discipline. First observable sign: analysts raising EPS, not revenue, estimates.